.Merck defeats profits assumptions, brings up sales expectation on sturdy demand for best medicines like Keytruda CNBCMerck & Co. (MRK US) Beats Earnings Projections as Keytruda Sales Surge BloombergMerck Sell: Pharma Titan Posts Powerful Results, Yet Outlook Drops Short Financier's Organization DailyMerck Announces Second-Quarter 2024 Financial Outcomes Yahoo FinanceMerck beats income and sales requirements amidst Keytruda strength, yet delivers mixed full-year overview MarketWatch.